KLTO
Klotho Neurosciences, Inc.
NASDAQ: KLTO · HEALTHCARE · BIOTECHNOLOGY
$0.52
+0.00% today
Updated 2026-04-30
Market cap
$56.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
9.5M
Klotho Neurosciences, Inc. (KLTO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating cash flow | $-165126.00 | $-284021.00 | $-599573.00 | $-446916.00 | $-2.95M |
| Capital expenditures | $0.00 | $0.00 | $125408.00 | $13888.00 | $123497.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $748015.00 | $821150.00 | $1400.00 | $0.00 | $2.65M |
| Free cash flow | $-165126.00 | $-284021.00 | $-724981.00 | $-460804.00 | $-3.07M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |